Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Continue

Publications

A blood atlas of COVID-19 defines hallmarks of disease severity and specificity

Ahern DJ. et al, (2021)

Lymphocyte Activation Gene (LAG)-3 Is Associated With Mucosal Inflammation and Disease Activity in Ulcerative Colitis

Slevin SM. et al, (2020), Journal of Crohn's and Colitis, 14, 1446 - 1461

T cell assays differentiate clinical and subclinical SARS-CoV-2 infections from cross-reactive antiviral responses

Ogbe A. et al, (2020)

TCR and Inflammatory Signals Tune Human MAIT Cells to Exert Specific Tissue Repair and Effector Functions

Leng T. et al, (2019), Cell Reports, 28, 3077 - 3091.e5

Systems-level analysis of monocyte responses in inflammatory bowel disease identifies IL-10 and IL-1 cytokine networks that regulate IL-23

Aschenbrenner D. et al, (2019)

The Short Chain Fatty Acid Butyrate Imprints an Antimicrobial Program in Macrophages

Schulthess J. et al, (2019), Immunity, 50, 432 - 445.e7

CD161 Defines a Functionally Distinct Subset of Pro-Inflammatory Natural Killer Cells

Kurioka A. et al, (2018), Frontiers in Immunology, 9

Host-microbial crosstalk in the pathogenesis of colon cancer in Primary sclerosing cholangitis

Neyazi M. et al, (2018), JOURNAL OF CROHNS & COLITIS, 12, S97 - S97

Innate Lymphoid Cells in Intestinal Inflammation

Geremia A. and Arancibia-Cárcamo CV., (2017), Frontiers in Immunology, 8

Th1 and Innate Lymphoid Cells Accumulate in Primary Sclerosing Cholangitis-associated Inflammatory Bowel Disease

Gwela A. et al, (2017), Journal of Crohn's and Colitis, 11, 1124 - 1134

Oncostatin M drives intestinal inflammation and predicts response to tumor necrosis factor–neutralizing therapy in patients with inflammatory bowel disease

West NR. et al, (2017), Nature Medicine, 23, 579 - 589

RORγt inhibitors suppress TH17 responses in inflammatory arthritis and inflammatory bowel disease

de Wit J. et al, (2016), Journal of Allergy and Clinical Immunology, 137, 960 - 963

Deletion of CTLA-4 on regulatory T cells during adulthood leads to resistance to autoimmunity

Paterson AM. et al, (2015), Journal of Experimental Medicine, 212, 1603 - 1621

SUPPRESSION OF IN-VITRO TYPE-17 RESPONSES IN SPA PATIENTS USING SMALL MOLECULE ROR-gamma T INHIBITORS

De Wit J. et al, (2014), CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 32, 811 - 811

Expression and regulation of the TGF-beta-activating integrin alpha(v)beta(8) on human dendritic cells

Fenton TM. et al, (2013), IMMUNOLOGY, 140, 147 - 148

Corrigendum

(2011), International Immunology, 23, 463 - 463

IL-23–responsive innate lymphoid cells are increased in inflammatory bowel disease

Geremia A. et al, (2011), Journal of Experimental Medicine, 208, 1127 - 1133

Auto-antibody production and glomerulonephritis in congenic Slamf1-/- and Slamf2-/- [B6.129] but not in Slamf1-/- and Slamf2-/- [BALB/c.129] mice

Keszei M. et al, (2011), International Immunology, 23, 149 - 158

Interleukin-23 Restrains Regulatory T Cell Activity to Drive T Cell-Dependent Colitis

Izcue A. et al, (2008), Immunity, 28, 559 - 570

A functionally specialized population of mucosal CD103+ DCs induces Foxp3+ regulatory T cells via a TGF-β– and retinoic acid–dependent mechanism

Coombes JL. et al, (2007), Journal of Experimental Medicine, 204, 1757 - 1764

Load More

Include forthcoming?